MELISSA GROENEVELD: Open Payments
NPI 1851671192 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 50 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $245 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $259 |
| Lilly USA, LLC | 10 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Madrigal Pharmaceuticals | 2 | $66 |
| Abbott Laboratories | 3 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Amgen Inc. | 2 | $36 |
| Alexion Pharmaceuticals, Inc. | 2 | $34 |
| Radius Health, Inc. | 2 | $32 |
| Ascendis Pharma Endocrinology Inc | 2 | $31 |
Products named: JARDIANCE, Ozempic, MOUNJARO, Rybelsus, REZDIFFRA, FREESTYLE LIBRE 3, Kerendia, Wegovy.
Industry payments across IA — which companies pay providers there.
